SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-14-060401
Filing Date
2014-10-09
Accepted
2014-10-09 16:30:27
Documents
7
Period of Report
2014-11-10
Effectiveness Date
2014-10-09

Document Format Files

Seq Description Document Type Size
1 DEF 14A v390771_def14a.htm DEF 14A 817114
2 GRAPHIC v390771_pxycrd1.jpg GRAPHIC 341043
3 GRAPHIC v390771_pxycrd2.jpg GRAPHIC 87358
4 GRAPHIC line.gif GRAPHIC 43
5 GRAPHIC logo_protalix.jpg GRAPHIC 4327
6 GRAPHIC sig_yossi-maimon.jpg GRAPHIC 1357
7 GRAPHIC spacer.gif GRAPHIC 43
  Complete submission text file 0001144204-14-060401.txt   1417470
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33357 | Film No.: 141150421
SIC: 2836 Biological Products, (No Diagnostic Substances)